Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-05-15

Clinical Trial Update: Controlled Human Malaria Infection (CHMI) After Immunization With Cryopreserved Plasmodium Falciparum Sporozoites Under Chloroquine Prophylaxis [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating immunity conferred by immunization with cryopreserved Plasmodium falciparum sporozoites under chloroquine prophylaxis; the study has co…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Chloroquine (chloroquine)

Snippet

Sponsor: Sanaria Inc. | Conditions: Malaria, Plasmodium Falciparum | Phase 1 | Status: COMPLETED